Showing results (381-390 of 452) with videos related to

Sort By:
Pageof 46
The World Allergy Organization Journal|July 11, 2018
Management of chronic spontaneous urticaria: a worldwide perspectivePavel Kolkhir, Dmitry Pogorelov, Razvigor Darlenski, et al.
Rhinology|January 12, 2026
Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspectiveM Caminati, A Mastrototaro, M Maule, et al.
Clinical and Molecular Allergy : CMA|February 20, 2016
Quality of life in patients with food allergyDarío Antolín-Amérigo, Luis Manso, Marco Caminati, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19Gianluigi Dorelli, Michele Braggio, Daniele Gabbiani, et al.
Nanoscale|November 5, 2020
Making biological membrane resistant to the toxicity of misfolded protein oligomers: a lesson from trodusquemineSilvia Errico, Giacomo Lucchesi, Davide Odino, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 2, 2024
Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION studyChristopher E Brightling, Marco Caminati, Jean-Pierre Llanos, et al.
The World Allergy Organization Journal|February 18, 2021
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real lifeDiego Bagnasco, Massimiliano Povero, Lorenzo Pradelli, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 6, 2020
Minimal clinically important difference for asthma endpoints: an expert consensus reportMatteo Bonini, Marcello Di Paolo, Diego Bagnasco, et al.
Recenti Progressi in Medicina|November 18, 2017
[OssERvare Project: direct observation of use of the Safety Surgery CheckList in the operating room.]Roberto Bentivegna, Annita Caminati, Vanni Agnoletti, et al.
The Lancet. Respiratory Medicine|May 18, 2026
Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trialMichael E Wechsler, Christopher E Brightling, Guy Brusselle, et al.
Pageof 46